Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aman Patel

Neurological Surgery Boston, MA Medical Doctor

NPI 1265408843 CMS profile 11360

15 Parkman St, Wac-745, Boston, MA 02114

Open in the dashboard

General payments

$733,817

896 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$98,576 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Aman Patel of Boston, MA is reported in the CMS Open Payments database as having received $733,817 across 896 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $98,576 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $81,786 100
2024 General $107,251 107
2023 General $113,053 165
2022 General $121,379 169
2021 General $121,306 103
2020 General $117,800 126
2019 General $71,241 126

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aman Patel
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Aman Patel were reported at $81,786. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Aman Patel Neurological Surgery median Middle half National median
2019 $71,241 $582 $138–$3,006 $163
2020 $117,800 $294 $76–$2,174 $114
2021 $121,306 $387 $105–$2,432 $132
2022 $121,379 $542 $139–$2,989 $149
2023 $113,053 $534 $145–$2,697 $160
2024 $107,251 $574 $155–$3,046 $164
2025 $81,786 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $597,158 644 payments
  2. Stryker Corporation $48,416 65 payments
  3. Penumbra, Inc. $44,938 76 payments
  4. Medtronic, Inc. $19,331 61 payments
  5. Medtronic USA, Inc. $11,123 16 payments
  6. Kaneka Pharma America LLC $6,074 3 payments
  7. Vasorum USA Inc. $3,305 8 payments
  8. Siemens Medical Solutions USA, Inc. $2,014 12 payments
  9. Route 92 Medical, Inc. $563 3 payments
  10. Orthofix Medical, Inc. $336 1 payment
  11. Other $557 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $455,031 142 payments
  2. Consulting Fee $161,396 31 payments
  3. Travel and Lodging $95,920 353 payments
  4. Food and Beverage $21,421 369 payments
  5. Entertainment $48 1 payment
Products named General payments · program years 2019–2025
  1. WEB ANEURYSM EMBOLIZATION SYSTEM Neurological Product $277,611 286 payments
  2. WEB $168,379 217 payments
  3. WEB Aneurysm Embolization System Neurological Product $114,345 83 payments
  4. SYNCHRO SELECT $44,763 14 payments
  5. HYDROSOFT ADVANCED $25,135 14 payments
  6. STENT $23,082 25 payments
  7. Smart Coil $19,692 8 payments
  8. Pipeline Flow Diversion $18,959 50 payments
  9. Penumbra System $16,218 34 payments
  10. Pipeline Flow Diversion $11,123 16 payments
  11. Other $30,492 180 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$268,466

Medicare's payments for the services billed

Medicare patients

451

Average age 74

Services billed

1,749

274 women, 177 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Ischemic heart disease 34%
Depression 33%
Chronic kidney disease 31%
Diabetes 27%
Atrial fibrillation 27%
Osteoporosis 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

896 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record